research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Neurofibromatosis Research Program: Clinical Trial Award (worldwide)

Share this post

ERC webinar 2024
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Neurofibromatosis Research Program: Clinical Trial Award from the Congressionally Directed Medical Research Programs (CDMRP) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. The program is open to researchers in the USA and worldwide. Applications are open to academic institutions as well as biotechnology companies. The award provides up to 800,000 USD over 4 years. Indirect costs may be covered.

Funding Opportunity Number: HT9425-23-NFRP-CTA

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 11, 2023. Application Submission Deadline: 11:59 p.m. ET, August 25, 2023.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time